Solid lipid nanoparticles for incorporation of trans-resveratrol in the topical treatment of melanoma: in vitro and in vivo evaluation and the elucidation of the mechanism of uptake cellular

• Grant number: 13/21500-1
• Support Opportunities: Scholarships in Brazil - Doctorate
• Start date: June 01, 2014
• End date: June 30, 2017
• Field of knowledge: Health Sciences - Pharmacy - Pharmaceutical Technology
• Agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
• Principal Investigator: Marlus Chorilli
• Grantee: Roberta Balansin Rigon
• Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil
• Associated scholarship(s): 16/02195-1 - Characterization of the penetrability of flexible and rigid nanoparticles into reconstructed human skin, BE.EP.DR

Abstract

The incidence of skin cancers has increased, and melanoma (MEL) is the most serious type. The treatment choice involves the administration of chemotherapy, which may have cytotoxic action also on healthy cells, affecting quality and survival of patients. Trans-resveratrol (RES) has shown excellent results in the prevention and treatment of MEL. However, this substance has low bioavailability and rapid metabolism in vivo. Thus, its topical administration may be convenient to locate the drug on their site of action. Nanostructured lipid systems such as solid lipid nanoparticles (SLN) are gaining notoriety as carriers for topical administration of drugs, in virtue of their interaction with the stratum corneum and other layers of the skin, and the ability of the drug with arrangement protective effect and sustainer of release. The effects caused by NLS vary according to their ability to reach the target tissue and enter the cell. The detailed characterization of the interactions that occur between these systems and biological systems is of crucial importance for the formulation development of high therapeutic efficiency. Data obtained by our research group showed that SLN consisting of stearic acid (SA) or polyoxyethylene (40) stearate (EP40) as a lipid phase and poloxamer 407 (P407) plus soy phosphatidylcholine (FS) as surfactants were shown to be nontoxic in cell models of human keratinocytes (HaCat) and enabled the controlled release and penetration of RES in the epidermis. The incorporation of cationic lipids such as glyceryl behenate (BH) in SLN may facilitate targeting to tumor cells, which have high negative charge because the exposure of phosphatidylserine (FS) on the surface of cell membranes. In this context, the present study has as objective the topical administration of SLN, composed of AE or EP40, P407/FS and water, with cationic lipid BG, for placement of RES in the treatment of MEL with evaluation their activity and efficiency in vitro / in vivo, as well as the research of the mechanisms of uptake cellular of these delivery systems. (AU)

Scientific publications

(5)

(The scientific publications listed on this page originate from the Web of Science or SciELO databases. Their authors have cited FAPESP grant or fellowship project numbers awarded to Principal Investigators or Fellowship Recipients, whether or not they are among the authors. This information is collected automatically and retrieved directly from those bibliometric databases.)

FONSECA-SANTOS, BRUNO; SILVA, PATRICIA BENTO; RIGON, ROBERTA BALASIN; SATO, MARIANA RILLO; CHORILLI, MARIUS. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Current Medicinal Chemistry, v. 27, n. 22, p. 3623-3656, 2020. (15/05394-2, 13/09265-7, 14/24180-0, 13/21500-1, 16/11198-4)

RIGON, ROBERTA BALANSIN; GONCALEZ, MAIRA LIMA; SEVERINO, PATRICIA; ALVES, DANILO ANTONINI; SANTANA, MARIA H. A.; SOUTO, ELIANA B.; CHORILLI, MARIUS. Solid lipid nanoparticles optimized by 2² factorial design for skin administration: Cytotoxicity in NIH3T3 fibroblasts. COLLOIDS AND SURFACES B-BIOINTERFACES, v. 171, p. 5-pg., 2018-11-01. (12/19568-4, 13/21500-1, 11/16888-5)

RIGON, ROBERTA B.; FACHINETTI, NAIARA; SEVERINO, PATRICIA; SANTANA, MARIA H. A.; CHORILLI, MARLUS. Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies. Molecules, v. 21, n. 1, JAN 2016. (12/19568-4, 11/16888-5, 13/21500-1)

RIGON, ROBERTA BALANSIN; GONCALEZ, MAIRA LIMA; SEVERINO, PATRICIA; ALVES, DANILO ANTONINI; SANTANA, MARIA H. A.; SOUTO, ELIANA B.; CHORILLI, MARIUS. Solid lipid nanoparticles optimized by 2(2) factorial design for skin administration: Cytotoxicity in NIH3T3 fibroblasts. COLLOIDS AND SURFACES B-BIOINTERFACES, v. 171, p. 501-505, NOV 1 2018. (13/21500-1, 12/19568-4, 11/16888-5)

FACHINETTI, NAIARA; RIGON, ROBERTA BALANSIN; ELOY, JOSIMAR O.; SATO, MARIANA RILLO; DOS SANTOS, KAREN CRISTINA; CHORILLI, MARLUS. Comparative Study of Glyceryl Behenate or Polyoxyethylene 40 Stearate-Based Lipid Carriers for Trans-Resveratrol Delivery: Development, Characterization and Evaluation of the In Vitro Tyrosinase Inhibition. AAPS PHARMSCITECH, v. 19, n. 3, p. 1401-1409, APR 2018. (13/21500-1, 11/19018-1, 12/19568-4, 11/16888-5)

Academic Publications

(References retrieved automatically from State of São Paulo Research Institutions)

RIGON, Roberta Balansin. Solid lipid nanoparticles for incorporation of trans-resveratrol in the topical treatment of melanoma: in vitro and in vivo evaluation and the elucidation of the mechanism of uptake cellular. 2017. Doctoral Thesis - Universidade Estadual Paulista (Unesp). Faculdade de Ciências Farmacêuticas. Araraquara Araraquara.